NO20024236D0 - Behandling av psoriasis - Google Patents

Behandling av psoriasis

Info

Publication number
NO20024236D0
NO20024236D0 NO20024236A NO20024236A NO20024236D0 NO 20024236 D0 NO20024236 D0 NO 20024236D0 NO 20024236 A NO20024236 A NO 20024236A NO 20024236 A NO20024236 A NO 20024236A NO 20024236 D0 NO20024236 D0 NO 20024236D0
Authority
NO
Norway
Prior art keywords
psoriasis
treatment
Prior art date
Application number
NO20024236A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024236L (no
Inventor
Holly Read Thomasson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20024236L publication Critical patent/NO20024236L/no
Publication of NO20024236D0 publication Critical patent/NO20024236D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024236A 2000-03-07 2002-09-05 Behandling av psoriasis NO20024236D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18750800P 2000-03-07 2000-03-07
PCT/US2001/005260 WO2001066101A2 (en) 2000-03-07 2001-02-20 Treatment of psoriasis

Publications (2)

Publication Number Publication Date
NO20024236L NO20024236L (no) 2002-09-05
NO20024236D0 true NO20024236D0 (no) 2002-09-05

Family

ID=22689272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024236A NO20024236D0 (no) 2000-03-07 2002-09-05 Behandling av psoriasis

Country Status (19)

Country Link
US (1) US6683114B2 (hu)
EP (1) EP1267859A2 (hu)
JP (1) JP2003525899A (hu)
KR (1) KR20020081403A (hu)
CN (1) CN1407890A (hu)
AU (1) AU4529101A (hu)
BR (1) BR0108980A (hu)
CA (1) CA2400571A1 (hu)
DZ (1) DZ3282A1 (hu)
EA (1) EA200200948A1 (hu)
HR (1) HRP20020729A2 (hu)
HU (1) HUP0204551A2 (hu)
IL (1) IL150479A0 (hu)
MX (1) MXPA02008659A (hu)
NO (1) NO20024236D0 (hu)
PL (1) PL357042A1 (hu)
SK (1) SK12812002A3 (hu)
WO (1) WO2001066101A2 (hu)
ZA (1) ZA200205266B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
CN2559015Y (zh) * 2002-04-29 2003-07-02 谢基生 电动式双层近红外滤光型防盗摄影监控装置
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (en) * 2003-02-28 2004-09-10 Amedis Pharmaceuticals Ltd. Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder
WO2005011583A2 (en) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Treatment of allergic rhinitis and asthma
WO2007146796A2 (en) * 2006-06-13 2007-12-21 Ramot At Tel-Aviv University Ltd. Antiproliferative compounds, compositions and methods of use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
US9326935B2 (en) * 2013-11-08 2016-05-03 Eli Lilly And Company Atomoxetine solution

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183323B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
EP1069900B1 (en) * 1998-04-09 2005-08-10 Pharmacia & Upjohn Company LLC Use of reboxetine for the treatment of neuropsychiatric disorders
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) * 2000-03-16 2002-06-11 President And Fellows Of Harvard College Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

Also Published As

Publication number Publication date
WO2001066101A2 (en) 2001-09-13
MXPA02008659A (es) 2003-02-24
WO2001066101A3 (en) 2002-02-07
NO20024236L (no) 2002-09-05
HRP20020729A2 (en) 2004-02-29
EA200200948A1 (ru) 2003-02-27
SK12812002A3 (sk) 2003-08-05
US20030045585A1 (en) 2003-03-06
BR0108980A (pt) 2003-06-03
DZ3282A1 (fr) 2001-09-13
HUP0204551A2 (hu) 2003-06-28
JP2003525899A (ja) 2003-09-02
CA2400571A1 (en) 2001-09-13
AU4529101A (en) 2001-09-17
PL357042A1 (en) 2004-07-12
US6683114B2 (en) 2004-01-27
ZA200205266B (en) 2003-10-01
EP1267859A2 (en) 2003-01-02
CN1407890A (zh) 2003-04-02
IL150479A0 (en) 2002-12-01
KR20020081403A (ko) 2002-10-26

Similar Documents

Publication Publication Date Title
NO20024005L (no) Pteridinforbindelser for behandling av psoriasis
NO20024273L (no) Terapeutiske anvendelser av PPAR-mediatorer
FIU20060389U0 (fi) Luusairauksien hoito
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20014950L (no) Nye behandlingsmetoder
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20020062L (no) Behandling av nevrotiske forstyrrelser
NO20024236L (no) Behandling av psoriasis
NO20041968L (no) Anvendelse av cystationin
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20030978L (no) Behandling av urindysfunksjon
NO20032156L (no) Behandling av angstforstyrrelser
DE60103685D1 (de) Behandlung von Poriomania
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
SE0300535L (sv) Behandling av brännskador
NO20014477L (no) Behandling av osteoartritis
NO20034972D0 (no) Behandling av ADHD
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
NO20030762L (no) Forbedret spesifisitet i behandling av sykdommer
NO20014476L (no) Behandling av hiatial hernia
NO20010171D0 (no) Teknisk behandling av tåke

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application